Studies indicate that GLP-1R (glucagon-like peptide-1 receptor), GIPR (glucose-dependent insulinotropic polypeptide receptor), and GCGR (glucagon receptor) act as crucial "regulators" in maintaining human blood glucose balance and are important therapeutic targets for type 2 diabetes and obesity
After years of "less pounding" feeling out of reach, more peaceful days might finally be on the horizon
Employers want to offer something for their members, but when they see the cost, they cant afford it. Employers who address obesity treatment effectively can drive significant value in their costs and employee satisfaction. Elina Onitskansky, founder and CEO, Ilant Health Weighing the Long-Term Benefits While GLP-1 drugs were originally developed to treat diabetes by managing blood sugar levels, they now are commonly prescribed to also treat obesity
If its clinically appropriate and safe, your provider can create a personalized treatment plan and may prescribe Wegovy
From the different pathogenesis of epileptogenesis: vitamins as an adjunctive treatment for epilepsy